UNSPSC 51112301: Busulfan

This classification denotes an alkylsulfonate compound with the molecular formula C6H14O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G1LN9045DK, chemically known as 1,4-dimethylsulfonyloxybutane but more generally known as busulfan, which bears US NIH Compound Identifier 2478. Busulfan most often comes in base and mannitol forms. European Medicines Agency schedules Busulfan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05993MIG.

UNSPSC 51112301 Busulfan is a Commodity code covering pharmaceutical procurement of this specific chemotherapy agent. State and local governments acquire busulfan primarily through health plans, state Medicaid programs, and state employee health benefit programs that manage pharmacy benefit spending and direct-to-patient prescription fulfillment. The issuing bodies soliciting under this code include state health and human services departments managing pharmacy benefits for Medicaid and employee populations, with procurement often structured through RFIs, RFPs, and cooperative purchasing arrangements rather than traditional commodities procurement.

The Texas Health and Human Services Commission posted an RFI (HHS0017013) on April 3, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program that would establish direct relationships between the state's pharmacy benefit program and pharmaceutical manufacturers outside traditional pharmacy benefit manager, group purchasing organization, and wholesaler channels. The RFI solicited vendor experience with direct contracting for self-insured employers and health plans, flexible pricing models using negotiated net pricing without rebates, and value-based or outcomes-based agreement capability. This represents preliminary market intelligence gathering; Texas HHS intends to use vendor responses to develop detailed procurement specifications and pricing models for subsequent formal solicitations. The source contains only this single recent opportunity and does not provide sufficient detail to characterize broader geographic or issuing-body concentration patterns under the code.